Skip to main content

Advertisement

Log in

Brain metastases from colorectal carcinoma: prognostic factors and outcome

  • Clinical Study – Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Brain metastases from colorectal carcinoma (CRC) are rare. The objectives of this study are to assess the natural history, outcome, and possible prognostic factors in CRC patients with brain metastases. Between 1995 and 2008, 8,732 patients with CRC were treated at Yonsei University Health System. Brain metastases were found in 1.4% of these patients. Retrospective review and statistical analysis of these 126 patients were performed. Median time from diagnosis of metastatic CRC (mCRC) to brain metastases was 9.0 months (range 0–85 months), and 14 patients (11.1%) had brain involvement as their initial presentation. Among the 126 patients, 91.3% had other systemic metastases; the most common extracranial metastatic site was lung (72.2%). Median follow-up duration was 6.1 months (range 0.1–90.3 months), and median survival after diagnosis of brain metastases was 5.4 months [95% confidence interval (CI) 3.9–6.9 months]. Median survival time after diagnosis of brain metastases was 1.5 months for patients who received only steroids (15.9%), 4.0 months for those who received whole-brain radiation therapy (37.5%), 9.5 months for those who received gamma-knife surgery (GKS) (32.5%), and 11.5 months for those who underwent surgery (20%) (P < 0.001). On multivariate analysis, recursive partitioning analysis (RPA) class and amount of chemotherapy before brain metastasis were independent prognostic factors for survival. Overall prognosis of patients with brain metastases from CRC is poor. Nevertheless, patients with low RPA class, or those with previous less chemotherapy showed good prognosis, indicating that proper treatment may result in improved survival time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    Article  PubMed  Google Scholar 

  2. Floyd CE, Stirling CT, Cohn I (1966) Cancer of the colon, rectum and anus: review of 1,687 cases. Ann Surg 163:829–837

    Article  CAS  PubMed  Google Scholar 

  3. Cascino TL, Leavengood JM, Kemeny N, Posner JB (1983) Brain metastases from colon cancer. J Neurooncol 1:203–209

    Article  CAS  PubMed  Google Scholar 

  4. O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR (2003) A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 55:1169–1176

    Article  PubMed  Google Scholar 

  5. Grothey A, Sargent D, Goldberg RM, Schmoll H (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22:1209–1214

    Article  CAS  PubMed  Google Scholar 

  6. van den Bent MJ (2001) The diagnosis and management of brain metastases. Curr Opin Neurol 14:717–723

    Article  PubMed  Google Scholar 

  7. Mehta MP et al (2003) Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21:2529–2536

    Article  CAS  PubMed  Google Scholar 

  8. Ewend MG, Carey LA, Morris DE, Harvey RD, Hensing TA (2001) Brain metastases. Curr Treat Options Oncol 2:537–547

    Article  CAS  PubMed  Google Scholar 

  9. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751

    Article  CAS  PubMed  Google Scholar 

  10. Hammoud MA, McCutcheon IE, Elsouki R, Schoppa D, Patt YZ (1996) Colorectal carcinoma and brain metastasis: distribution, treatment, and survival. Ann Surg Oncol 3:453–463

    Article  CAS  PubMed  Google Scholar 

  11. Fasola G et al (2009) Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases. J Cancer Res Clin Oncol 135:451–457

    Article  PubMed  Google Scholar 

  12. Balteskard L, Pawinski A, Nieder C (2009) Colorectal cancer metastatic to the brain: time trends in presentation and outcome. Oncology 76:369–374

    Article  PubMed  Google Scholar 

  13. Farnell GF, Buckner JC, Cascino TL, O’Connell MJ, Schomberg PJ, Suman V (1996) Brain metastases from colorectal carcinoma. The long term survivors. Cancer 78:711–716

    Article  CAS  PubMed  Google Scholar 

  14. Wroński M, Arbit E (1999) Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 85:1677–1685

    Article  PubMed  Google Scholar 

  15. Kruser TJ, Chao ST, Elson P, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Pelley R, Suh JH (2008) Multidisciplinary management of colorectal brain metastases: a retrospective study. Cancer 113:158–165

    Article  PubMed  Google Scholar 

  16. Chyun Y, Hayward E, Lokich J (1980) Metastasis to the central nervous system from colorectal cancer. Med Pediatr Oncol 8:305–308

    Article  CAS  PubMed  Google Scholar 

  17. Cohen SJ, Wang H, Rogatko A, Meropol NJ, Sundermeyer ML (2005) Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 5:108–113

    Article  PubMed  Google Scholar 

  18. Fowler A, Cook R, Biggs M, Little N, Assaad N, McDonald K (2008) Survival of patients following neurosurgical treatment of colorectal adenocarcinoma metastasis in the Northern Sydney-Central Coast area. J Clin Neurosci 15:998–1004

    Article  CAS  PubMed  Google Scholar 

  19. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865–2872

    Article  PubMed  Google Scholar 

  20. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698–2705

    Article  PubMed  Google Scholar 

  21. Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21:1–23, vii

    Google Scholar 

  22. Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ (2005) Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 5:108–113

    Article  PubMed  Google Scholar 

  23. Kim TJ, Song S, Kim CK, Kim WY, Choi CH, Lee JH, Lee JW, Bae DS, Kim BG (2007) Prognostic factors associated with brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer 17:1252–1257

    Article  PubMed  Google Scholar 

  24. Gaspar LE, Scott C, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:1001–1006

    Article  CAS  PubMed  Google Scholar 

  25. Choi HJ, Cho BC, Sohn JH, Shin SJ, Kim SH, Kim JH, Yoo NC (2009) Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J Neurooncol 91:307–313

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by a Korea Science and Engineering Foundation (KOSEF) grant funded by the Ministry of Science and Technology (MOST) of Korea (R11-2000-082-02008-0).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sang Joon Shin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, M., Ahn, J.B., Chang, J.H. et al. Brain metastases from colorectal carcinoma: prognostic factors and outcome. J Neurooncol 101, 49–55 (2011). https://doi.org/10.1007/s11060-010-0214-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0214-9

Keywords

Navigation